Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001193125-17-027562
Filing Date
2017-02-01
Accepted
2017-02-01 16:57:03
Documents
3
Period of Report
2017-02-24

Document Format Files

Seq Description Document Type Size
1 PRELIMINARY PROXY STATEMENT d338856dpre14a.htm PRE 14A 133960
2 GRAPHIC g338856img001.jpg GRAPHIC 204099
3 GRAPHIC g338856img002.jpg GRAPHIC 138886
  Complete submission text file 0001193125-17-027562.txt   607667
Mailing Address 25134 RYE CANYON LOOP SUITE 300 VALENCIA CA 91355
Business Address 25134 RYE CANYON LOOP SUITE 300 VALENCIA CA 91355 6617755300
MANNKIND CORP (Filer) CIK: 0000899460 (see all company filings)

EIN.: 133607736 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 000-50865 | Film No.: 17565603
SIC: 2834 Pharmaceutical Preparations